Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Approved - SO WHY DID THEY SELL TO KEDRION?
View:
Post by stockman6767 on Jun 04, 2021 4:26pm

Approved - SO WHY DID THEY SELL TO KEDRION?

Approved - SO WHY DID THEY SELL TO KEDRION FOR A MERE $5 M?  NOW THEY REALLY LOOK STUPID!
Comment by stockbuphoon on Jun 04, 2021 5:31pm
Either they are irretrievably stupid or they are planning to go private or maybe just sell small molecule division on Monday? Who announces that their lead indication for 4050 will not go to phase 2 trial in middle of a phase 1 trial a week before a PDUFA date? who knows - maybe they announce a financing at $3.75 on Monday morning. Anything is possible with these clowns!   
Comment by stockman6767 on Jun 04, 2021 5:35pm
The only place my mind goes on this is some very nefarious underhanded and under the table doings.  I can not come up with any logical, legitimate reason for their actions since they took over the company.
Comment by stockbuphoon on Jun 04, 2021 6:00pm
The money was always on 4050 kidney and liver.and yet they put IPF out in the presentations as their lead indication only to pull it. This action alone tells me that Tomfvck is playing the long game here and will go back to Boehringher and another at the table in 2018 and sell it to highest bidder. No way that they hang around for another 2-3 years for kidney and liver results. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities